Diantha Duvall

Diantha Duvall is the Chief Financial Officer at Genocea Biosciences. Diantha has over 20 years of experience in finance and accounting. Prior to joining Genocea, Diantha served as the Vice President and Chief Accounting Officer at BioTheryX, Inc. Diantha also served as Global Commercial Controller at Biogen and as Emerging Business Acting CFO and Business Development Controller at Merck. Diantha has a deep understanding of financial evaluation and cadence for disparate wholly owned businesses. Diantha is also experienced in business development, joint ventures, alliances, royalty, and dispositions. Diantha is a board member of GHIF and is actively involved in GHIF's investments in various innovative health companies.

Diantha Duvall studied economics as an undergraduate at Colby College before earning their Master of Business Administration with a concentration in accounting from Northeastern University.

Diantha Duvall works with Raymond D. Stapleton - Chief Technology Officer, Girish Aakalu - Chief Business Officer, and Jacquelyn Sumer - Chief Legal & Compliance Officer. Diantha Duvall reports to Chip Clark, President & CEO.